A Phase II Trial of Trastuzumab Combined with Irinotecan in Patients with Advanced HER2-positive Chemo-refractory Gastric Cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group ：OGSG1203 (HERBIS-5)

Kawabata, D. Sakai, J. Kawada, K. Nishikawa, T. Kawase, Y. Oka, N. Sugimoto, T. Shimizu, J. Nishijima, H. Hasegawa, S. Endo, Y. Isozaki, Y. Kimura, J. Matsuyama, Y. Kurokawa, T. Shimokawa, K. Fujitani, T. Satoh ESMO-ASIA 2015 , Singapore ,18 – 21 Dec 2015